Treatment of Cellulitis
Beta-lactam monotherapy is the standard of care for typical uncomplicated cellulitis and should be your first-line treatment, with oral agents such as cephalexin, dicloxacillin, or amoxicillin for 5 days. 1, 2
First-Line Antibiotic Selection for Uncomplicated Cellulitis
For outpatient management of typical nonpurulent cellulitis:
- Oral beta-lactam monotherapy is successful in 96% of cases because β-hemolytic streptococci and methicillin-sensitive S. aureus are the primary pathogens 1, 3
- Recommended oral agents include:
Critical point: MRSA is an uncommon cause of typical cellulitis even in high-prevalence settings, so routine MRSA coverage is unnecessary and represents overtreatment 1, 2, 4
Treatment Duration
- Treat for 5 days if clinical improvement occurs 1, 2
- Extend treatment only if symptoms have not improved within this 5-day timeframe 1, 2
- Traditional 7-14 day courses are no longer necessary for uncomplicated cases 1
When to Add MRSA Coverage
Add MRSA-active antibiotics ONLY when specific risk factors are present: 1, 2
- Penetrating trauma or injection drug use 1
- Purulent drainage or exudate 1
- Evidence of MRSA infection elsewhere or known MRSA colonization 1
- Systemic inflammatory response syndrome (SIRS) 1
- Failure to respond to beta-lactam therapy after 48-72 hours 1
If MRSA coverage is needed, choose one of these regimens:
- Clindamycin monotherapy 300-450 mg every 6 hours (covers both streptococci and MRSA, avoiding need for combination therapy) 1
- Trimethoprim-sulfamethoxazole (Bactrim) PLUS a beta-lactam (e.g., cephalexin) 1
- Doxycycline 100 mg twice daily PLUS a beta-lactam 1
Common pitfall: Never use doxycycline or Bactrim as monotherapy for typical cellulitis—their activity against β-hemolytic streptococci is unreliable 1, 4
Inpatient/IV Antibiotic Management
For hospitalized patients requiring IV therapy:
Uncomplicated cellulitis without MRSA risk factors:
Complicated cellulitis or MRSA coverage needed:
- Vancomycin 15-20 mg/kg IV every 8-12 hours (first-line, A-I evidence) 1
- Linezolid 600 mg IV twice daily (equally effective alternative, A-I evidence) 1, 5
- Daptomycin 4 mg/kg IV once daily (A-I evidence) 1
- Clindamycin 600 mg IV every 8 hours (if local MRSA resistance <10%) 1
Severe cellulitis with systemic toxicity or suspected necrotizing fasciitis:
- Vancomycin 15-20 mg/kg IV every 8-12 hours PLUS piperacillin-tazobactam 3.375-4.5 g IV every 6 hours 1
- Alternative combinations: vancomycin plus a carbapenem, or vancomycin plus ceftriaxone and metronidazole 1
- For documented group A streptococcal necrotizing fasciitis: penicillin plus clindamycin 1
Treatment duration for severe infections: 7-14 days guided by clinical response 1
Indications for Hospitalization
Admit patients with any of the following: 1, 2
- Systemic inflammatory response syndrome (SIRS): fever >38°C, tachycardia >90 bpm, tachypnea >24 rpm 1
- Hypotension or hemodynamic instability 1
- Altered mental status or confusion 1
- Severe immunocompromise or neutropenia 1
- Concern for deeper or necrotizing infection (severe pain out of proportion to exam, skin anesthesia, rapid progression, gas in tissue, bullous changes) 1
Adjunctive Measures
These interventions accelerate recovery and prevent recurrence: 1, 2
- Elevate the affected extremity to promote gravitational drainage of edema 1, 2
- Examine and treat interdigital toe spaces for tinea pedis, fissuring, or maceration 1, 2
- Address predisposing conditions: venous insufficiency, lymphedema, chronic edema, obesity, eczema 1, 2, 6
- Consider systemic corticosteroids (e.g., prednisone 40 mg daily for 7 days) in non-diabetic adults, though evidence is limited 1, 2
Special Situations
Bite-associated cellulitis (human or animal):
- Amoxicillin-clavulanate 875/125 mg twice daily as monotherapy (provides polymicrobial coverage) 1
- Do NOT add Bactrim to this regimen 1
Penicillin allergy:
- Clindamycin 300-450 mg every 6 hours (covers both streptococci and MRSA) 1
- Cefuroxime 500 mg twice daily if only mild penicillin allergy 1
Pediatric dosing:
- Cephalexin or clindamycin at weight-based doses 1
- Vancomycin 15 mg/kg IV every 6 hours for hospitalized children 1
- Never use doxycycline in children <8 years due to tooth discoloration 1
Reassessment and Treatment Failure
Mandatory reassessment at 48-72 hours to verify clinical response: 1
- If spreading despite appropriate antibiotics, consider:
Do not continue ineffective antibiotics beyond 48 hours—progression indicates either resistant organisms or a different/deeper infection 1